We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group.
- Authors
Bamias, A; Aravantinos, G; Kalofonos, C; Timotheadou, N; Siafaka, V; Vlahou, I; Janinis, D; Pectasides, D; Pavlidis, N; Fountzilas, G; Hellenic Cooperative Oncology Group
- Abstract
Platinum compounds are commonly associated with significant anemia. Erythropoietin administration has been found effective in correcting anemia in patients with solid tumors receiving chemotherapy. We conducted a randomized, open label study to assess the efficacy of erythropoietin in preventing transfusions and significant anemia (hemoglobin <10 g/dl) in patients with solid tumors receiving platinum-based chemotherapy.
- Publication
Oncology, 2003, Vol 64, Issue 2, p102
- ISSN
0030-2414
- Publication type
Journal Article
- DOI
10.1159/000067766